Our findings showed that KAJD reduced the serum levels of IgE and Th2 cytokines, such as IL-6 and IL-10, and the infiltration of mast cells and leukocytes, including eosinophils and monocytes, into AD skin lesions. The gene discussed is IGHE; the disease is Alzheimer disease.